Insider Shareholders with Direct Ownership of Kiniksa Pharmaceuticals, Ltd. (KNSA)
This section provides a comprehensive overview of the insiders with direct ownership of Kiniksa Pharmaceuticals, Ltd. (KNSA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Kiniksa Pharmaceuticals, Ltd. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Thomas W. Beetham
EVP & Chief Legal Officer |
300,000 | 2,477 | 297,523 $12 Million | 2 |
Feb 03, 2021
Reduced 0.83%
|
|
Sanj K Patel
CHAIRMAN & CEO |
936,631 | 941,271 | 111,794 $4.51 Million | 71 |
Oct 22, 2025
Reduced 46.56%
|
|
John F. Paolini
CHIEF MEDICAL OFFICER |
356,520 | 326,414 | 61,324 $2.47 Million | 56 |
Oct 31, 2025
Reduced 57.37%
|
|
Mark Ragosa
CHIEF FINANCIAL OFFICER |
340,825 | 316,918 | 31,086 $1.25 Million | 80 |
Nov 12, 2025
Reduced 39.03%
|
|
Michael R Megna
CHIEF ACCOUNTING OFFICER |
215,130 | 189,667 | 27,046 $1.09 Million | 77 |
Oct 20, 2025
Reduced 32.86%
|
|
Eben Tessari
CHIEF OPERATING OFFICER |
547,826 | 632,441 | 22,714 $915,828 | 88 |
Nov 17, 2025
Reduced 34.24%
|
| 18,474 | 0 | 18,474 $744,871 | 7 |
Jul 01, 2025
Added 5.62%
|
|
| 29,680 | 0 | 14,840 $598,348 | 1 |
Jun 06, 2019
Added 50.0%
|
|
| 12,546 | 0 | 12,546 $505,854 | 3 |
Jun 05, 2025
Added 20.19%
|
|
| 61,953 | 49,407 | 12,546 $505,854 | 11 |
Jun 11, 2025
Reduced 49.58%
|
|
| 190,315 | 177,769 | 12,546 $505,854 | 9 |
Aug 14, 2025
Reduced 86.18%
|
|
| 77,054 | 64,508 | 12,546 $505,854 | 5 |
Jul 30, 2025
Reduced 83.72%
|
|
| 12,546 | 0 | 12,546 $505,854 | 3 |
Jun 05, 2025
Added 20.19%
|
|
|
Ross Moat
CHIEF CORP. & COMM. OFFICER |
235,982 | 231,853 | 9,415 $379,612 | 55 |
Sep 04, 2025
Reduced 27.23%
|
|
Qasim Rizvi
Chief Commercial Officer |
7,337 | 2,161 | 5,176 $208,696 | 2 |
Dec 31, 2020
Reduced 29.45%
|